• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用 NNIBP 的疏水通道:发现新型二芳基嘧啶类化合物作为 HIV-1 NNRTIs,针对野生型和 K103N 突变病毒。

Exploiting the hydrophobic channel of the NNIBP: Discovery of novel diarylpyrimidines as HIV-1 NNRTIs against wild-type and K103N mutant viruses.

机构信息

Department of Medicinal Chemistry, Key Laboratory of Chemical Biology (Ministry of Education), School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, 44 West Culture Road, 250012 Jinan, Shandong, PR China.

Rega Institute for Medical Research, Laboratory of Virology and Chemotherapy, K.U. Leuven, Herestraat 49 Postbus 1043 (09.A097), B-3000 Leuven, Belgium.

出版信息

Bioorg Med Chem. 2021 Jul 15;42:116239. doi: 10.1016/j.bmc.2021.116239. Epub 2021 May 28.

DOI:10.1016/j.bmc.2021.116239
PMID:34090079
Abstract

To further explore the chemical space surrounding the "hydrophobic channel" of the NNRTI binding pocket (NNIBP), a new series of diarylpyrimidines (DAPYs) were designed and synthesized as potent HIV-1 non-nucleoside RT inhibitors (NNRTIs). The target compounds were evaluated for anti-HIV potency in MT-4 cells. Most of the synthesized DAPYs exhibited moderate to excellent activity against the HIV-1 wild-type (WT) strain with EC values ranging from 16 nM to 0.722 µM. Interestingly, few compounds displayed remarkable activity in inhibiting K103N mutant virus with EC values ranging from 39 nM to 1.708 µM. Notably, FS2 (EC = 16 nM, EC = 39 nM, SI = 294) was identified as the most significant compound, which was considerably more potent than nevirapine, lamivudine, and comparable to zidovudine. Additionally, the HIV-1 RT inhibition assay confirmed their binding target. Preliminary structure-activity relationships (SARs) and molecular modeling studies were also performed, providing significant suggestions for further optimization.

摘要

为了进一步探索 NNRTI 结合口袋(NNIBP)“疏水通道”周围的化学空间,设计并合成了一系列新的二芳基嘧啶(DAPY)作为有效的 HIV-1 非核苷 RT 抑制剂(NNRTIs)。评估了目标化合物在 MT-4 细胞中的抗 HIV 效力。大多数合成的 DAPY 对 HIV-1 野生型(WT)株表现出中等至优异的活性,EC 值范围为 16 nM 至 0.722 μM。有趣的是,少数化合物对 K103N 突变病毒表现出显著的抑制活性,EC 值范围为 39 nM 至 1.708 μM。值得注意的是,FS2(EC=16 nM,EC=39 nM,SI=294)被鉴定为最显著的化合物,其效力明显优于奈韦拉平、拉米夫定,与齐多夫定相当。此外,HIV-1 RT 抑制测定法证实了它们的结合靶标。还进行了初步的构效关系(SAR)和分子建模研究,为进一步优化提供了重要建议。

相似文献

1
Exploiting the hydrophobic channel of the NNIBP: Discovery of novel diarylpyrimidines as HIV-1 NNRTIs against wild-type and K103N mutant viruses.利用 NNIBP 的疏水通道:发现新型二芳基嘧啶类化合物作为 HIV-1 NNRTIs,针对野生型和 K103N 突变病毒。
Bioorg Med Chem. 2021 Jul 15;42:116239. doi: 10.1016/j.bmc.2021.116239. Epub 2021 May 28.
2
Targeting the hydrophobic channel of NNIBP: discovery of novel 1,2,3-triazole-derived diarylpyrimidines as novel HIV-1 NNRTIs with high potency against wild-type and K103N mutant virus.针对 NNIBP 的疏水通道:新型 1,2,3-三唑衍生的二芳基嘧啶类化合物作为新型 HIV-1 NNRTIs 的发现,对野生型和 K103N 突变病毒具有高活性。
Org Biomol Chem. 2019 Mar 20;17(12):3202-3217. doi: 10.1039/c9ob00032a.
3
Discovery of novel diarylpyrimidines as potent HIV-1 NNRTIs by investigating the chemical space of a less explored "hydrophobic channel".通过研究一个探索较少的“疏水通道”的化学空间,发现新型二芳基嘧啶类作为有效的 HIV-1 NNRTIs。
Org Biomol Chem. 2018 Feb 7;16(6):1014-1028. doi: 10.1039/c7ob02828h.
4
Discovery of novel indolylarylsulfones as potent HIV-1 NNRTIs via structure-guided scaffold morphing.通过结构导向的骨架变形发现新型吲哚芳基砜类作为有效的 HIV-1 NNRTIs。
Eur J Med Chem. 2019 Nov 15;182:111619. doi: 10.1016/j.ejmech.2019.111619. Epub 2019 Aug 14.
5
Design, synthesis, and antiviral evaluation of novel piperidine-substituted arylpyrimidines as HIV-1 NNRTIs by exploring the hydrophobic channel of NNIBP.设计、合成新型哌啶取代的嘧啶并芳基类化合物作为 HIV-1 NNRTIs,通过探索 NNIBP 的疏水通道进行抗 HIV 活性评价。
Bioorg Chem. 2021 Nov;116:105353. doi: 10.1016/j.bioorg.2021.105353. Epub 2021 Sep 11.
6
Design of the naphthyl-diarylpyrimidines as potent non-nucleoside reverse transcriptase inhibitors (NNRTIs) via structure-based extension into the entrance channel.通过基于结构的方法将萘基-二芳基嘧啶类化合物设计成有效的非核苷逆转录酶抑制剂(NNRTIs),进入入口通道。
Eur J Med Chem. 2021 Dec 15;226:113868. doi: 10.1016/j.ejmech.2021.113868. Epub 2021 Sep 22.
7
Design, synthesis and evaluation of novel HIV-1 NNRTIs with dual structural conformations targeting the entrance channel of the NNRTI binding pocket.针对非核苷类逆转录酶抑制剂(NNRTI)结合口袋入口通道,设计、合成及评估具有双重结构构象的新型HIV-1非核苷类逆转录酶抑制剂。
Eur J Med Chem. 2016 Jun 10;115:53-62. doi: 10.1016/j.ejmech.2016.02.068. Epub 2016 Mar 3.
8
Discovery of biphenyl-substituted diarylpyrimidines as non-nucleoside reverse transcriptase inhibitors with high potency against wild-type and mutant HIV-1.发现联苯取代的二芳基嘧啶作为非核苷逆转录酶抑制剂,对野生型和突变型 HIV-1 具有高活性。
Eur J Med Chem. 2018 Feb 10;145:726-734. doi: 10.1016/j.ejmech.2018.01.016. Epub 2018 Jan 8.
9
Design, synthesis and anti-HIV evaluation of novel diarylpyridine derivatives targeting the entrance channel of NNRTI binding pocket.设计、合成及新型二芳基吡啶类化合物针对 NNRTI 结合口袋入口通道的抗 HIV 活性评价。
Eur J Med Chem. 2016 Feb 15;109:294-304. doi: 10.1016/j.ejmech.2015.11.039. Epub 2015 Dec 22.
10
Fragment hopping-based discovery of novel sulfinylacetamide-diarylpyrimidines (DAPYs) as HIV-1 nonnucleoside reverse transcriptase inhibitors.基于片段 hopping 的新型磺酰基乙酰胺-二芳基嘧啶(DAPYs)类 HIV-1 非核苷逆转录酶抑制剂的发现。
Eur J Med Chem. 2020 Jan 1;185:111874. doi: 10.1016/j.ejmech.2019.111874. Epub 2019 Nov 10.

引用本文的文献

1
Design and Synthesis of Novel HIV-1 NNRTIs with Bicyclic Cores and with Improved Physicochemical Properties.新型 HIV-1 NNRTIs 的设计与合成:具有双环核心和改善的物理化学性质。
J Med Chem. 2023 Feb 9;66(3):1761-1777. doi: 10.1021/acs.jmedchem.2c01574. Epub 2023 Jan 18.
2
Identification of Novel Diarylpyrimidines as Potent HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors by Exploring the Primer Grip Region.通过探索引物结合区鉴定新型二芳基嘧啶作为有效的HIV-1非核苷类逆转录酶抑制剂
Pharmaceuticals (Basel). 2022 Nov 19;15(11):1438. doi: 10.3390/ph15111438.